Athanasia Xirogianni

Dr. Athanasia Xirogianni

University of West Attica, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
GTGeorgina Tzanakaki
Georgina Tzanakaki
EHEva Hong
Eva Hong
KKKonstatinos Kesanopoulos
Konstatinos Kesanopoulos
AXAthanasia Xirogianni
Athanasia Xirogianni
SBStefania Bambini
Stefania Bambini
MTMuhamed-Kheir Taha
Muhamed-Kheir Taha
Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in order to find whether the aforementioned vaccine will cover the MenB strains circulating in Greece. A panel of 148 serogroup B invasive meningococcal strains was characterized by multilocus sequence typing (MLST) and PorA subtyping. Vaccine components were typed by sequencing for factor H-binding protein (fHbp), Neisserial Heparin Binding Antigen (NHBA) and Neisseria adhesin A (NadA). Their expression was explored by Meningococcal Antigen Typing System (MATS).

1 January 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
CACharalampos Antachopoulos
Charalampos Antachopoulos
MTMaria N. Tsolia
Maria N. Tsolia
GTGeorgina Tzanakaki
Georgina Tzanakaki
AXAthanasia Xirogianni
Athanasia Xirogianni
ODOlga Dedousi
Olga Dedousi
Emmanuel RoilidesEmmanuel Roilides
Emmanuel Roilides
During 2012, Streptococcus pneumoniae serotype 3 was identified by polymerase chain reaction in 15 out of 20 (75%) pleural fluid specimens from children with pneumococcal pneumonia complicated by parapneumonic pleural effusion in Greece. One-third of these children had been immunized with the 13-valent conjugated pneumococcal vaccine after the age of 12 months, according to the national immunization schedule.

28 March 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
AMAlexios-Fotios Mentis
Alexios-Fotios Mentis
IGIrene García
Irene García
JJJuan Jimenez
Juan Jimenez
MPMaria Paparoupa
Maria Paparoupa
AXAthanasia Xirogianni
Athanasia Xirogianni
GTGeorgina Tzanakaki
Georgina Tzanakaki
Differential diagnosis between bacterial and viral meningitis is crucial. In our study, to differentiate bacterial vs. viral meningitis, three machine learning (ML) algorithms (multiple logistic regression (MLR), random forest (RF), and naïve-Bayes (NB)) were applied for the two age groups (0–14 and >14 years) of patients with meningitis by both conventional (culture) and molecular (PCR) methods. Cerebrospinal fluid (CSF) neutrophils, CSF lymphocytes, neutrophil-to-lymphocyte ratio (NLR), blood albumin, blood C-reactive protein (CRP), glucose, blood soluble urokinase-type plasminogen activator receptor (suPAR), and CSF lymphocytes-to-blood CRP ratio (LCR) were used as predictors for the ML algorithms. The performance of the ML algorithms was evaluated through a cross-validation procedure, and optimal predictions of the type of meningitis were above 95% for viral and 78% for bacterial meningitis. Overall, MLR and RF yielded the best performance when using CSF neutrophils, CSF lymphocytes, NLR, albumin, glucose, gender, and CRP. Also, our results reconfirm the high diagnostic accuracy of NLR in the differential diagnosis between bacterial and viral meningitis.

20 January 2016 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AMAlexios-Fotios Mentis
Alexios-Fotios Mentis
MKMiltiades Kyprianou
Miltiades Kyprianou
AXAthanasia Xirogianni
Athanasia Xirogianni
KKK. Kesanopoulos
K. Kesanopoulos
GTGeorgina Tzanakaki
Georgina Tzanakaki

1 January 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
PGPolyvios Giannakopoulos
Polyvios Giannakopoulos
ACARISTEIDIS CHRYSOVERGIS
ARISTEIDIS CHRYSOVERGIS
AXAthanasia Xirogianni
Athanasia Xirogianni
TNThomas P. Nikolopoulos
Thomas P. Nikolopoulos
ARAlexandros Radiotis
Alexandros Radiotis
MTMaria N. Tsolia
Maria N. Tsolia
In the post–heptavalent pneumococcal conjugate vaccine era, Streptococcus pneumoniae remains the leading cause of acute mastoiditis and other complicated or refractory acute otitis media among hospitalized children in our settings. Serotype 19A is predominant, invasive and multidrug resistant causing more than half of all mastoiditis cases, two-thirds of cases with subperiosteal abscess and all those requiring mastoidectomy. Continuous surveillance is required.

1 February 2009 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AXAthanasia Xirogianni
Athanasia Xirogianni
GTGeorgina Tzanakaki
Georgina Tzanakaki
EKEleni Karagianni
Eleni Karagianni
PMPanayiotis Markoulatos
Panayiotis Markoulatos
JKJenny Kourea-Kremastinou
Jenny Kourea-Kremastinou